Hepatitis C Drug Market for Hospitals, Private labs, Physician Offices, Public Health Labs and Blood Banks - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global Hepatitis C drug market worth $33.50 by 2022, growing at a CAGR of 16.0% between 2017 and 2022.

16-Mar-2017 | Number of pages: 110 | Report Code: ZMR-1326 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the Hepatitis C drug market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the Hepatitis C drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hepatitis C drug market on a global level.

This report offers comprehensive coverage on global Hepatitis C drug market along with, market trends, drivers, and restraints of Hepatitis C drug market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the Hepatitis C drug market has also been included. The study encompasses a market attractiveness analysis, wherein each segment are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the Hepatitis C drug market by segmenting the market based on End-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. The End-user market covered under this study includes hospitals, private labs, physician offices, public health labs and blood bank. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., U.K., Germany, France, Japan, China, India, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global Hepatitis C drug market include Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

This report segments the global Hepatitis C drug market as follows:

Global Hepatitis C Drug Market:  End-User Analysis

  • Hospitals
  • Private labs
  • Physician offices
  • Public health labs
  • Blood Bank

Global Hepatitis C Drug Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Contrast Media/Contrast Agent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1359 | Report Format:

Global Contrast Media/Contrast Agent Market: Overview To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is v...Read More

Continuous Renal Replacement Therapy (CRRT) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1358 | Report Format:

Global Continuous Renal Replacement Therapy (CRRT) Market: Overview A process wherein extracorporeal blood purification is done to substitute for the renal dysfunction for an extended period of time is known as continuous renal replacement therapy (CRRT). It is a therapy of renal replacement for...Read More

Superdisintegrants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1354 | Report Format:

Global Superdisintegrants Market: Overview Superdisintegrant is a kind of excipient that is used for the tablet-based drug delivery in the pharmaceutical industry. To help the solid dosage form drugs such as pills or tablets disintegrate when they are submerged in the liquid superdisintegrants a...Read More

Medication Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1349 | Report Format:

Global Medication Management Market: Overview To manage and support the medicine management cycle an advanced system is developed known as medication management. In the hospitals, the medication management system is used for prescribing, supplying and administering the medicines. The use of the ...Read More

Eubiotics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1313 | Report Format:

Global Eubiotics Market: Overview To maintain the optimal balance of the dubious which is present in the gastrointestinal tract eubiotic products are used. In a simple way, it can be said that eubiotics help in improving the immune system thus being used on a large scale. It helps in keeping the...Read More

Choose License Type: